When can cannabis businesses challenge compliance standards?
For a cannabis business, one potential risk of new product development is that state regulators will determine the new product does not comply with existing standards.
US Medical Marijuana Business News
For a cannabis business, one potential risk of new product development is that state regulators will determine the new product does not comply with existing standards.
Today’s cannabis market environment presents an unparalleled opportunity for investors, thanks to unique deal structures and compelling valuations.
While Hunter Biden walks free, thousands of Americans are incarcerated for nonviolent marijuana offenses despite the president’s promises.
The National Cannabis Roundtable and the U.S. Cannabis Council – two large lobbying groups that advocate on behalf of the state-regulated marijuana industry in Washington, D.C. – are merging to form the US Cannabis Roundtable.
Finance experts disagree over the validity of rumors about a “wall of capital” entering the cannabis sector if marijuana is rescheduled.
Here are seven MJBizDaily predictions for developments in 2025 that could impact the U.S. marijuana and hemp industries.
The future looks sunnier for the marijuana industry. How companies respond to macroeconomic factors will decide the health of their cannabis businesses.